Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbin Pharmaceutical Group No. 2 Traditional Chinese Medicine Factory is a specialized manufacturing unit of the Harbin Pharmaceutical Group, focusing on the production of Traditional Chinese Medicine (TCM). The facility is a major producer of anti-viral and anti-inflammatory herbal medications, with its flagship product being the Shuanghuanglian oral liquid and injection. It integrates traditional herbal knowledge with modern pharmaceutical manufacturing standards, including advanced extraction and concentration processes. The company's products are widely distributed across China for the treatment of respiratory ailments and infectious diseases. As a key component of the Hayao Group, it contributes significantly to the group's portfolio of natural and herbal health solutions. The factory operates under strict Good Manufacturing Practice (GMP) standards to ensure the quality and consistency of its herbal formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harbin Pharmaceutical Group No. Two Traditional Chinese Medicine Factory.